Manufacturers Life Insurance Company, The Pliant Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 75,268 shares of PLRX stock, worth $927,301. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,268

Previous 83,483 9.84%

Holding current value

$927,301

Previous $897,000 6.02%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$10.52 - $14.35 $86,421 - $117,885	-8,215 Reduced 9.84%	75,268 $843,000
Q2 2024 Aug 14, 2024	BUY	$10.58 - $15.61 $12,600 - $18,591	1,191 Added 1.45%	83,483 $897,000
Q1 2024 May 14, 2024	BUY	$14.14 - $19.59 $104,876 - $145,299	7,417 Added 9.91%	82,292 $1.23 Million
Q4 2023 Feb 13, 2024	BUY	$12.85 - $19.15 $98,867 - $147,340	7,694 Added 11.45%	74,875 $1.36 Million
Q3 2023 Nov 15, 2023	SELL	$14.58 - $20.15 $9,928 - $13,722	-681 Reduced 1.0%	67,181 $1.16 Million
Q2 2023 Aug 11, 2023	BUY	$18.12 - $30.56 $710,648 - $1.2 Million	39,219 Added 136.92%	67,862 $1.23 Million
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $228,693 - $442,734	12,210 Added 42.63%	40,853 $1.09 Million
Q4 2022 Aug 11, 2023	BUY	$17.0 - $25.43 $3,451 - $5,162	203 Added 0.71%	28,643 $553,000
Q4 2022 Feb 13, 2023	BUY	$17.0 - $25.43 $3,451 - $5,162	203 Added 0.71%	28,643 $553,000
Q3 2022 Aug 11, 2023	BUY	$7.67 - $24.23 $131,463 - $415,302	17,140 Added 151.68%	28,440 $594,000
Q3 2022 Nov 03, 2022	BUY	$7.67 - $24.23 $218,134 - $689,101	28,440 New	28,440 $590,000
Q2 2022 Aug 15, 2022	SELL	$4.11 - $8.75 $46,443 - $98,875	-11,300 Closed	0 $0
Q1 2022 Aug 11, 2023	SELL	$7.01 - $14.1 $207,166 - $416,697	-29,553 Reduced 72.34%	11,300 $79,000
Q1 2022 May 20, 2022	SELL	$7.01 - $14.1 $15,400 - $30,977	-2,197 Reduced 16.28%	11,300 $79,000
Q4 2021 Feb 16, 2022	BUY	$12.27 - $18.26 $6,908 - $10,280	563 Added 4.35%	13,497 $182,000
Q3 2021 Nov 12, 2021	SELL	$16.48 - $28.98 $11,404 - $20,054	-692 Reduced 5.08%	12,934 $218,000
Q2 2021 Aug 12, 2021	BUY	$28.05 - $37.69 $7,769 - $10,440	277 Added 2.08%	13,626 $397,000
Q1 2021 May 03, 2021	BUY	$24.52 - $40.23 $327,317 - $537,030	13,349 New	13,349 $525,000

Others Institutions Holding PLRX

# of Institutions

168

Shares Held

63.2M

Call Options Held

245K

Put Options Held

373K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Pliant Therapeutics, Inc. Transaction History